RxDoctor Payments Data

Felix Savoie, MD

Sports Medicine · New Orleans, LANPI 1437147659

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,244,320 of the $1,356,756 with a category attached, or 91.7%. Linvatec Corporation accounts for 64.5% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $306,194, 2.3 times the $134,024 reported in 2019. Among sports medicine clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,356,756in general payments, 2019–2025

Across 134 payments — averaging $10,125 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$875K
  • Exactech, Inc.$250K
  • Zimmer Biomet$143K
  • Smith+Nephew$82K
  • Medical Device Business Services, Inc.$5K
  • Synthes GmbH$1K
  • plus $1K from 7 others
$30,671in research payments, 2019–2025

Across 10 payments — averaging $3067.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$29K
  • Smith+Nephew$2K

What the payments were for

  • Royalty or licence$1,244,32092%
  • Consulting fees$27,7552%
  • Speaking & faculty fees$72,9685%
  • Travel & lodging$5,6700%
  • Food & beverage$2,3440%
  • Other$3,6990%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,356,756 in reported general payments places this provider in the 95th percentile of 82 sports medicine providers in Louisiana.

See all sports medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$232,762
Medicare patients
391
Services billed
1,445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl135$600
Prednisone235$570
Doxycycline Monohydrate32$525
Tramadol Hcl162$444
Celecoxib22$258
Cyclobenzaprine Hcl39$152
Cephalexin13$109
Gabapentin42$88
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$86
Amoxicillin19$71

Paid to pharmacies, not to this prescriber.

Other sports medicine in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →